These effects, along with a preceding report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the strategy of focusing on ACKR3 as a unique approach to modulate the opioid method, which could open up new therapeutic avenues for opioid-relevant Problems.We independently study, assessment, and a